Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Moderna, Inc.MRNA · Entity 2025 | Chief Financial Officer | October 05, 2026 | October 07, 2026 |
| REVVITY, INC.PKI · Entity 3382 | Please See Remarks | June 24, 2022 | June 27, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Moderna, Inc.
Report date October 05, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,125 |
Ending reported balance
After 2026-10-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-05 · Exercise / conversion · Acquired 1,454 · Balance 60,829 F1: Restricted stock units convert into common stock on a one-for-one basis. Row 2 · 2026-10-05 · Tax withholding · Disposed 704 · Balance 60,125 F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-10-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-10-05 · Exercise / conversion · Disposed 1,454 · Balance 0 F1: Restricted stock units convert into common stock on a one-for-one basis. F3: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
REVVITY, INC.
Report date June 24, 2022 · Filed June 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,577 |
Ending reported balance
After 2022-06-24 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-06-24 · Sale · Disposed 2,072 · Balance 30,530 F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022. F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $144.27 to $145.11. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Row 2 · 2022-06-24 · Sale · Disposed 2,290 · Balance 28,240 F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022. F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $145.27 to $146.26. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Row 3 · 2022-06-24 · Sale · Disposed 663 · Balance 27,577 F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022. F4: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $146.28 to $146.40. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022.
F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $144.27 to $145.11. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $145.27 to $146.26. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F4: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $146.28 to $146.40. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2023 Filed Oct 10, 2023 20:51 UTC | Moderna, Inc. MRNA · Entity 2025 | Exercise / conversionCommon Stock | 5,810 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-025714 · form4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:29 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantRestricted Stock Units · Derivative | 5,260 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008446 · form4.xml · derivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,260 Underlying: Common Stock · 5,260 shares Expires not disclosed F2 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award will vest on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F2 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award will vest on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:29 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 20,040 | $0.00 Strike: $138.81 | $0.00 |
DisclosureSEC source: 0001127602-23-008446 · form4.xml · derivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,040 Underlying: Common Stock · 20,040 shares Expires 2033-02-28 F1 · derivative.exercise_date: 25% of this option will vest and become exercisable on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:07 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantRestricted Stock Units · Derivative | 23,242 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023803 · form4.xml · derivative · entry 2 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,242 Underlying: Common Stock · 23,242 shares Expires not disclosed F2 · derivative.exercise_date: 25% of the shares subject to this restricted stock unit award will vest on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F2 · derivative.expiration_date: 25% of the shares subject to this restricted stock unit award will vest on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:07 UTC | Moderna, Inc. MRNA · Entity 2025 | GrantStock Option (Right to Buy) · Derivative | 43,876 | $0.00 Strike: $125.62 | $0.00 |
DisclosureSEC source: 0001127602-22-023803 · form4.xml · derivative · entry 1 Mock James M · CIK 0001736359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,876 Underlying: Common Stock · 43,876 shares Expires 2032-10-05 F1 · derivative.exercise_date: 25% of this option will vest and become exercisable on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 663 | $146.34 | $97,023.42 |
DisclosureSEC source: 0000899243-22-024186 · doc4.xml · nonDerivative · entry 3 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,577 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022. F4 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $146.28 to $146.40. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 2,290 | $145.78 | $333,836.20 |
DisclosureSEC source: 0000899243-22-024186 · doc4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,240 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022. F3 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $145.27 to $146.26. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 24, 2022 Filed Jun 27, 2022 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 2,072 | $144.90 | $300,232.80 |
DisclosureSEC source: 0000899243-22-024186 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,530 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on May 23, 2022. F2 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $144.27 to $145.11. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 1,448 | $182.95 | $264,911.60 |
DisclosureSEC source: 0000899243-22-005208 · doc4.xml · nonDerivative · entry 4 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,602 F4 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 5, 2019, as required by the Reporting Person's Restricted Stock Agreement. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 4,998 | $182.95 | $914,384.10 |
DisclosureSEC source: 0000899243-22-005208 · doc4.xml · nonDerivative · entry 3 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,050 F3 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of performance-based restricted stock units originally granted on February 5, 2019, as required by the Reporting Person's Performance-based Restricted Stock Unit Agreement. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 13,054 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-005208 · doc4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,048 F2 · shares: Shares of common stock issued upon vesting of performance-based restricted stock units in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on February 5, 2019. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantNQ Stock Option (right to buy) · Derivative | 9,771 | $0.00 Strike: $184.61 | $0.00 |
DisclosureSEC source: 0000899243-22-005208 · doc4.xml · derivative · entry 5 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,771 Underlying: Common Stock · 9,771 shares Expires 2029-02-04 F5 · derivative.exercise_date: This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 2,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-005208 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,994 F1 · shares: Shares are time-based restricted stock that are scheduled to fully vest on the third anniversary of the date of grant. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 100 | $187.99 | $18,799.00 |
DisclosureSEC source: 0000899243-21-036768 · doc4.xml · nonDerivative · entry 6 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,244 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on August 20, 2021. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 1,100 | $187.17 | $205,887.00 |
DisclosureSEC source: 0000899243-21-036768 · doc4.xml · nonDerivative · entry 5 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,344 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on August 20, 2021. F6 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $186.83 to $187.78. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 400 | $186.09 | $74,436.00 |
DisclosureSEC source: 0000899243-21-036768 · doc4.xml · nonDerivative · entry 4 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,444 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on August 20, 2021. F5 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $185.75 to $186.62. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 1,377 | $185.30 | $255,158.10 |
DisclosureSEC source: 0000899243-21-036768 · doc4.xml · nonDerivative · entry 3 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,844 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on August 20, 2021. F4 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $184.75 to $185.70. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 1,803 | $183.93 | $331,625.79 |
DisclosureSEC source: 0000899243-21-036768 · doc4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,221 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on August 20, 2021. F3 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $183.60 to $184.16. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2021 Filed Sep 21, 2021 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 1,300 | $183.18 | $238,134.00 |
DisclosureSEC source: 0000899243-21-036768 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,024 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on August 20, 2021. F2 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $182.58 to $183.52. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 17, 2021 Filed May 18, 2021 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 4,005 | $143.50 | $574,717.50 |
DisclosureSEC source: 0000899243-21-019755 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,324 F1 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on May 15, 2018, as required by the Reporting Person's Restricted Stock Agreement. Read SEC document |
| April 06, 2021 Filed Apr 7, 2021 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 543 | $130.99 | $71,127.57 |
DisclosureSEC source: 0000899243-21-015256 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,329 F1 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock units originally granted on April 6, 2020, as required by the Reporting Person's Restricted Stock Unit Agreement. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 23:47 UTC | REVVITY, INC. PKI · Entity 3382 | GrantNQ Stock Option (right to buy) · Derivative | 11,125 | $0.00 Strike: $144.33 | $0.00 |
DisclosureSEC source: 0000899243-21-005241 · doc4.xml · derivative · entry 2 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,125 Underlying: Common Stock · 11,125 shares Expires 2028-02-05 F2 · derivative.exercise_date: This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 23:47 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 2,678 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005241 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,872 F1 · shares: Shares are time-based restricted stock that are scheduled to fully vest on the third anniversary of the date of grant. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 22:13 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 1,774 | $147.07 | $260,902.18 |
DisclosureSEC source: 0000899243-21-004222 · doc4.xml · nonDerivative · entry 3 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,194 F3 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on May 15, 2018, as required by the Reporting Person's Restricted Stock Agreement. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 22:13 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 2,810 | $147.07 | $413,266.70 |
DisclosureSEC source: 0000899243-21-004222 · doc4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,968 F2 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of performance-based restricted stock units originally granted on May 15, 2018, as required by the Reporting Person's Performance-based Restricted Stock Unit Agreement. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 22:13 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 8,560 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-004222 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,778 F1 · shares: Shares of common stock issued upon vesting of performance-based restricted stock units in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on May 15, 2018. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 100 | $125.08 | $12,508.00 |
DisclosureSEC source: 0000899243-20-027231 · doc4.xml · nonDerivative · entry 3 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on September 2, 2020. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 4,423 | $124.58 | $551,017.34 |
DisclosureSEC source: 0000899243-20-027231 · doc4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,318 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on September 2, 2020. F3 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $123.99 to $124.98. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 1,100 | $123.69 | $136,059.00 |
DisclosureSEC source: 0000899243-20-027231 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,741 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on September 2, 2020. F2 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $122.95 to $123.93 The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 2,950 | $91.97 | $271,311.50 |
DisclosureSEC source: 0000899243-20-013559 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,841 F1 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on May 15, 2018, as required by the Reporting Person's Restricted Stock Agreement. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 1,124 | $75.13 | $84,446.12 |
DisclosureSEC source: 0000899243-20-010390 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,791 F1 · shares: The reporting person was granted time-based restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 6, 2021, which is the first anniversary of the date on which the grant was made, subject to the reporting person's continued service through that date. F2 · price: Restricted stock units were awarded in lieu of a percentage of the reporting person's base salary pursuant to the issuer's voluntary equity for salary program, with the number of restricted stock units determined by dividing the amount of salary deferred by the Black-Scholes value of a restricted stock unit on the date the grant was made. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 22:37 UTC | REVVITY, INC. PKI · Entity 3382 | GrantNQ Stock Option (right to buy) · Derivative | 15,817 | $0.00 Strike: $96.06 | $0.00 |
DisclosureSEC source: 0000899243-20-002474 · doc4.xml · derivative · entry 2 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,817 Underlying: Common Stock · 15,817 shares Expires 2027-01-30 F2 · derivative.exercise_date: This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| January 30, 2020 Filed Jan 31, 2020 22:37 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 3,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-002474 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,567 F1 · shares: Shares are time-based restricted stock that are scheduled to fully vest on the third anniversary of the date of grant. Read SEC document |
| May 15, 2019 Filed May 16, 2019 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 3,406 | $89.04 | $303,270.24 |
DisclosureSEC source: 0000899243-19-013738 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,947 F1 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on May 15, 2018, as required by the Reporting Person's Restricted Stock Agreement. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:37 UTC | REVVITY, INC. PKI · Entity 3382 | GrantNQ Stock Option (right to buy) · Derivative | 13,598 | $0.00 Strike: $92.09 | $0.00 |
DisclosureSEC source: 0000899243-19-002890 · doc4.xml · derivative · entry 2 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,598 Underlying: Common Stock · 13,598 shares Expires 2026-02-05 F2 · derivative.exercise_date: This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:37 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 3,264 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002890 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,353 F1 · shares: Shares are time-based restricted stock that are scheduled to fully vest on the third anniversary of the date of grant. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:06 UTC | REVVITY, INC. PKI · Entity 3382 | GrantNQ Stock Option (right to buy) · Derivative | 17,038 | $0.00 Strike: $73.83 | $0.00 |
DisclosureSEC source: 0000899243-18-013200 · doc4.xml · derivative · entry 3 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,038 Underlying: Common Stock · 17,038 shares Expires 2025-05-15 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning on January 30, 2019, and has a 7 year exercise term. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:06 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-013200 · doc4.xml · nonDerivative · entry 2 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,089 F2 · shares: Shares are time-based restricted stock that will vest in full on January 30, 2021. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:06 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 27,089 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-013200 · doc4.xml · nonDerivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,089 F1 · shares: Shares are time-based restricted stock that will vest in three equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
| May 15, 2018 Filed Jun 5, 2018 20:05 UTC Amendment | REVVITY, INC. PKI · Entity 3382 | GrantNQ Stock Option (right to buy) · Derivative | 17,038 | $0.00 Strike: $74.41 | $0.00 |
DisclosureSEC source: 0000899243-18-015082 · doc4a.xml · derivative · entry 1 Mock James M · CIK 0001736359 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,038 Underlying: Common Stock · 17,038 shares Expires 2025-05-15 F1 · derivative.exercise_price: The original Form 4 incorrectly reported an exercise price of $73.83. F2 · derivative.exercise_date: This option vests in three equal annual installments beginning on January 30, 2019, and has a 7 year exercise term. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.